Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'CORECEPTOR' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 386 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Hansen, J; Qing, K; Srivastava, A
      Infection of purified nuclei by adeno-associated virus 2

      MOLECULAR THERAPY
    2. Duan, DS; Yue, YP; Engelhardt, JF
      Expanding AAV packaging capacity with trans-splicing or overlapping vectors: A quantitative comparison

      MOLECULAR THERAPY
    3. Holmes, EC
      On the origin and evolution of the human immunodeficiency virus (HIV)

      BIOLOGICAL REVIEWS
    4. Dowd, CS; Zhang, WT; Li, CZ; Chaiken, IM
      From receptor recognition mechanisms to bioinspired mimetic antagonists inHIV-1/cell docking

      JOURNAL OF CHROMATOGRAPHY B
    5. Keir, SD; Xiao, X; Li, J; Kennedy, PGE
      Adeno-associated virus-mediated delivery of glial cell line-derived neurotrophic factor protects motor neuron-like cells from apoptosis

      JOURNAL OF NEUROVIROLOGY
    6. McDonald, RA; Chang, G; Michael, NL
      Relationship between V3 genotype, biologic phenotype, tropism, and coreceptor use for primary isolates of human immunodeficiency virus type 1

      JOURNAL OF HUMAN VIROLOGY
    7. Shanmugasundaram, GK; Sundaresan, G; Shoeb, F; Arumugam, N; Kumaravelu, J; Unwalla, H; Chakraborti, S; Banerjea, AC
      Genetic analyses of cis-acting sequences controlling expression of human immunodeficiency virus type 1 coreceptor-CCR5 gene in rabbits and CXCR4 genein monkeys

      JOURNAL OF HUMAN VIROLOGY
    8. Grivel, JC; Ito, Y; Faga, G; Santoro, F; Shaheen, F; Malnati, MS; Fitzgerald, W; Lusso, P; Margolis, L
      Suppression of CCR5-but not CXCR4-tropic HIV-1 in lymphoid tissue by humanherpesvirus 6

      NATURE MEDICINE
    9. Eckstein, DA; Penn, ML; Korin, YD; Scripture-Adams, DD; Zack, JA; Kreisberg, JF; Roederer, M; Sherman, MP; Chin, PS; Goldsmith, MA
      HIV-1 actively replicates in naive CD4(+) T cells residing within human lymphoid tissues

      IMMUNITY
    10. Kenakin, TP
      Quantitation in receptor pharmacology

      RECEPTORS & CHANNELS
    11. Cheng, PC; Cherukuri, A; Dykstra, M; Malapati, S; Sproul, T; Chen, MR; Pierce, SK
      Floating the raft hypothesis: the roles of lipid rafts in B cell antigen receptor function

      SEMINARS IN IMMUNOLOGY
    12. BouHamdan, M; Strayer, DS; Wei, D; Mukhtar, M; Duan, LX; Hoxie, J; Pomerantz, RJ
      Inhibition of HIV-1 infection by down-regulation of the CXCR4 co-receptor using an intracellular single chain variable fragment against CXCR4

      GENE THERAPY
    13. Tamamura, H; Omagari, A; Hiramatsu, K; Kanamoto, T; Gotoh, K; Kanbara, K; Yamamoto, N; Nakashima, H; Otaka, A; Fujii, N
      Synthesis and evaluation of bifunctional anti-HIV agents based on specificCXCR4 antagonists-AZT conjugation

      BIOORGANIC & MEDICINAL CHEMISTRY
    14. Polzer, S; Dittmar, MT; Schmitz, H; Meyer, B; Muller, H; Krausslich, HG; Schreiber, M
      Loss of N-linked glycans in the V3-loop region of gp120 is correlated to an enhanced infectivity of HIV-1

      GLYCOBIOLOGY
    15. Dittmar, MT; Eichler, S; Reinberger, S; Henning, L; Krausslich, HG
      A recombinant virus assay using full-length envelope sequences to detect changes in HIV-1 co-receptor usage

      VIRUS GENES
    16. Teramoto, S; Ishii, T; Matsuse, T
      Variables pertinent to the efficiency of adeno-associated virus (AAV) vectors mediated gene transfer to human vascular endothelial cells

      Hypertension research
    17. Mitra, P; De, A; Ethier, MF; Mimori, K; Kodys, K; Shibuta, K; Mori, M; Madison, JM; Miller-Graziano, C; Barnard, GF
      Loss of chemokine SDF-1 alpha-mediated CXCR4 signalling and receptor internalization in human hepatoma cell line HepG2

      CELLULAR SIGNALLING
    18. Kanbara, K; Sato, S; Tanuma, J; Tamamura, H; Gotoh, K; Yoshimori, M; Kanamoto, T; Kitano, M; Fujii, N; Nakashima, H
      Biological and genetic characterization of a human immunodeficiency virus strain resistant to CXCR4 antagonist t134

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    19. Doranz, BJ; Filion, LG; Diaz-Mitoma, F; Sitar, DS; Sahai, J; Baribaud, FD; Orsini, MJ; Benovic, JL; Cameron, W; Doms, RW
      Safe use of the CXCR4 inhibitor ALX40-4C in humans

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    20. Ferraro, GA; Mello, MAG; Sutmoller, F; Van Weyenbergh, J; Shindo, N; Galvao-Castro, B; Bou-Habib, DC
      Biological characterization and chemokine receptor usage of HIV type 1 isolates prevalent in Brazil

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    21. Salvatori, F; Scarlatti, G
      HIV type 1 chemokine receptor usage in mother-to-child transmission

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    22. Singh, A; Yi, YJ; Isaacs, SN; Kolson, DL; Collman, RG
      Concordant utilization of macrophage entry coreceptors by related variantswithin an HIV type 1 primary isolate viral swarm

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    23. Bakri, Y; Amzazi, S; Mannioui, A; Benjouad, A
      The susceptibility of macrophages to human immunodeficiency virus type 1 X4 isolates depends on their activation state

      BIOMEDICINE & PHARMACOTHERAPY
    24. Gupta, SK; Pillarisetti, K; Aiyar, N
      CXCR4 undergoes complex lineage and inducing agent-dependent dissociation of expression and functional responsiveness to SDF-1 alpha during myeloid differentiation

      JOURNAL OF LEUKOCYTE BIOLOGY
    25. Foda, M; Harada, S; Maeda, Y
      Role of V3 independent domains on a dualtropic human immunodeficiency virus type 1 (HIV-1) envelope gp120 in CCR5 coreceptor utilization and viral infectivity

      MICROBIOLOGY AND IMMUNOLOGY
    26. Wang, FS; Jin, L; Lei, ZY; Shi, H; Hong, WG; Xu, DP; Jiang, JD; Wang, Y; Zhang, B; Liu, MX; Li, YQ
      Genotypes and polymorphisms of mutant CCR5-Delta 32, CCR2-64I and SDF1-3 'A HIV-1 resistance alleles in indigenous Han Chinese

      CHINESE MEDICAL JOURNAL
    27. Kaleebu, P; Ross, A; Morgan, D; Yirrell, D; Oram, J; Rutebemberwa, A; Lyagoba, F; Hamilton, L; Biryahwaho, B; Whitworth, J
      Relationship between HIV-1 Env subtypes A and D and disease progression ina rural Ugandan cohort

      AIDS
    28. Unwalla, H; Banerjea, AC
      Inhibition of HIV-1 gene expression by novel macrophage-tropic DNA enzymestargeted to cleave HIV-1 TAT/Rev RNA

      BIOCHEMICAL JOURNAL
    29. Atemezem, A; Mbemba, E; Vassy, R; Slimani, H; Saffar, L; Gattegno, L
      Human alpha(1)-acid glycoprotein binds to CCR5 expressed on the plasma membrane of human primary macrophages

      BIOCHEMICAL JOURNAL
    30. Stillwell, R; Bierer, BE
      T cell signal transduction and the role of CD7 in costimulation

      IMMUNOLOGIC RESEARCH
    31. Morris, L; Williamson, C
      Host and viral factors that impact on HIV-1 transmission and disease progression in South Africa

      SOUTH AFRICAN MEDICAL JOURNAL
    32. Davis, D; Trischmann, H; Stephens, DM; Lachmann, PJ
      Antibodies raised to short synthetic peptides with sequences derived from HIV-1SF2 gp120 can both neutralize and enhance HIV-1SF13: A later variant isolated from the same host

      JOURNAL OF MEDICAL VIROLOGY
    33. Baribaud, F; Doms, RW
      The impact of chemokine receptor conformational heterogeneity on HIV infection

      CELLULAR AND MOLECULAR BIOLOGY
    34. Auewarakul, P; Paungcharoen, V; Louisirirotchanakul, S; Wasi, C
      Application of HIV-1-green fluorescent protein (GFP) reporter viruses in neutralizing antibody assays

      ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY
    35. Mori, T; Boyd, MR
      Cyanovirin-N, a potent human immunodeficiency virus-inactivating protein, blocks both CD4-dependent and CD4-independent binding of soluble gp120 (sgp120) to target cells, inhibits sCD4-induced binding of sgp120 to cell-associated CXCR4, and dissociates bound sgp120 from target cells

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    36. Takashima, K; Miyake, H; Furuta, RA; Fujisawa, J; Iizawa, Y; Kanzaki, N; Shiraishi, M; Okonogi, K; Baba, M
      Inhibitory effects of small-molecule CCR5 antagonists on human immunodeficiency virus type 1 envelope-mediated membrane fusion and viral replication

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    37. Resch, W; Hoffman, N; Swanstrom, R
      Improved success of phenotype prediction of the human immunodeficiency virus type 1 from envelope variable loop 3 sequence using neural networks

      VIROLOGY
    38. Aarons, EJ; Beddows, S; Willingham, T; Wu, LJ; Koup, RA
      Adaptation to blockade of human immunodeficiency virus type 1 entry imposed by the anti-CCR5 monoclonal antibody 2D7

      VIROLOGY
    39. Yi, YJ; Singh, A; Isaacs, SN; Collman, RG
      A CCR5/CXCR4-independent coreceptor pathway on human macrophages supports efficient SIV Env-mediated fusion but not infection: Implications for alternative pathways of viral entry

      VIROLOGY
    40. Ghezzi, S; Menzo, S; Brambilla, A; Bordignon, PP; Lorini, AL; Clementi, M; Poli, G; Vicenzi, E
      Inhibition of R5X4 dualtropic HIV-1 primary isolates by single chemokine co-receptor ligands

      VIROLOGY
    41. Spenlehauer, C; Gordon, CA; Trkola, A; Moore, JP
      A luciferase-reporter gene-expressing T-cell line facilitates neutralization and drug-sensitivity assays that use either R5 or X4 strains of human immunodeficiency virus type 1

      VIROLOGY
    42. Seisenberger, G; Ried, MU; Endress, T; Buning, H; Hallek, M; Brauchle, C
      Real-time single-molecule imaging of the infection pathway of an adeno-associated virus

      SCIENCE
    43. Tamamura, H
      Development of selective antagonists against an HIV second receptor

      YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN
    44. Strizki, JM; Xu, S; Wagner, NE; Wojcik, L; Liu, J; Hou, Y; Endres, M; Palani, A; Shapiro, S; Clader, JW; Greenlee, WJ; Tagat, JR; McCombie, S; Cox, K; Fawzi, AB; Chou, CC; Pugliese-Sivo, C; Davies, L; Moreno, ME; Ho, DD; Trkola, A; Stoddart, CA; Moore, JP; Reyes, GR; Baroudy, BM
      SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    45. Shioda, T; Nakayama, EE; Tanaka, Y; Xin, XM; Liu, HL; Kawana-Tachikawa, A; Kato, A; Sakai, Y; Nagai, Y; Iwamoto, A
      Naturally occurring deletional mutation in the C-terminal cytoplasmic tailof CCR5 affects surface trafficking of CCR5

      JOURNAL OF VIROLOGY
    46. York, J; Follis, KE; Trahey, M; Nyambi, PN; Zolla-Pazner, S; Nunberg, JH
      Antibody binding and neutralization of primary and T-cell line-adapted isolates of human immunodeficiency virus type 1

      JOURNAL OF VIROLOGY
    47. Beaumont, T; van Nuenen, A; Broersen, S; Blattner, WA; Lukashov, VV; Schuitemaker, H
      Reversal of human immunodeficiency virus type 1 IIIB to a neutralization-resistant phenotype in an accidentally infected laboratory worker with a progressive clinical course

      JOURNAL OF VIROLOGY
    48. Tanaka, R; Yoshida, A; Murakami, T; Baba, E; Lichtenfeld, J; Omori, T; Kimura, T; Tsurutani, N; Fujii, N; Wang, ZX; Peiper, SC; Yamamoto, N; Tanaka, Y
      Unique monoclonal antibody recognizing the third extracellular loop of CXCR4 induces lymphocyte agglutination and enhances human immunodeficiency virus type 1-mediated syncytium formation and productive infection

      JOURNAL OF VIROLOGY
    49. Misumi, S; Nakajima, R; Takamune, N; Shoji, S
      A cyclic dodecapeptide-multiple-antigen peptide conjugate from the undecapeptidyl arch (from Arg(168) to Cys(178)) of extracellular loop 2 in CCR5 asa novel human immunodeficiency virus type 1 vaccine

      JOURNAL OF VIROLOGY
    50. Lin, G; Lee, B; Haggarty, BS; Doms, RW; Hoxie, JA
      CD4-Independent use of rhesus CCR5 by human immunodeficiency virus type 2 implicates an electrostatic interaction between the CCR5 N terminus and thegp120 C4 domain

      JOURNAL OF VIROLOGY
    51. Trkola, A; Ketas, TJ; Nagashima, KA; Zhao, L; Cilliers, T; Morris, L; Moore, JP; Maddon, PJ; Olson, WC
      Potent, broad-spectrum inhibition of human immunodeficiency virus type 1 by the CCR5 monoclonal antibody PRO 140

      JOURNAL OF VIROLOGY
    52. Sabbe, R; Picchio, GR; Pastore, C; Chaloin, O; Hartley, O; Offord, R; Mosier, DE
      Donor- and ligand-dependent differences in C-C chemokine receptor 5 reexpression

      JOURNAL OF VIROLOGY
    53. Baribaud, F; Edwards, TG; Sharron, M; Brelot, T; Heveker, N; Price, K; Mortari, F; Alizon, M; Tsang, M; Doms, RW
      Antigenically distinct conformations of CXCR4

      JOURNAL OF VIROLOGY
    54. Novitsky, V; Rybak, N; McLane, MF; Gilbert, P; Chigwedere, P; Klein, I; Gaolekwe, S; Chang, SY; Peter, T; Thior, I; Ndung'U, T; Vannberg, F; Foley, BT; Marlink, R; Lee, TH; Essex, M
      Identification of human immunodeficiency virus type 1 subtype C Gag-, Tat-, Rev-, and Nef-specific Elispot-based cytotoxic T-lymphocyte responses forAIDS vaccine design

      JOURNAL OF VIROLOGY
    55. Tokunaga, K; Greenberg, ML; Morse, MA; Cumming, RI; Lyerly, HK; Cullen, BR
      Molecular basis for cell tropism of CXCR4-dependent human immunodeficiencyvirus type 1 isolates

      JOURNAL OF VIROLOGY
    56. Lane, BR; Strieter, RM; Coffey, MJ; Markovitz, DM
      Human immunodeficiency virus type 1 (HIV-1)-induced GRO-alpha production stimulates HIV-1 replication in macrophages and T lymphocytes

      JOURNAL OF VIROLOGY
    57. Labrosse, B; Treboute, C; Brelot, A; Alizon, M
      Cooperation of the V1/V2 and V3 domains of human immunodeficiency virus type 1 gp120 for interaction with the CXCR4 receptor

      JOURNAL OF VIROLOGY
    58. Cormier, EG; Tran, DNH; Yukhayeva, L; Olson, WC; Dragic, T
      Mapping the determinants of the CCRS amino-terminal sulfopeptide interaction with soluble human immunodeficiency virus type 1 gp120-CD4 complexes

      JOURNAL OF VIROLOGY
    59. Edwards, TG; Hoffman, TL; Baribaud, F; Wyss, S; LaBranche, CC; Romano, J; Adkinson, J; Sharron, M; Hoxie, JA; Doms, RW
      Relationships between CD4 independence, neutralization sensitivity, and exposure of a CD4-induced epitope in a human immunodeficiency virus type 1 envelope protein

      JOURNAL OF VIROLOGY
    60. Van der Meer, P; Goldberg, SH; Fung, KM; Sharer, LR; Gonzalez-Scarano, F; Lavi, E
      Expression pattern of CXCR3, CXCR4, and CCR3 chemokine receptors in the developing human brain

      JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
    61. Navenot, JM; Wang, ZX; Trent, JO; Murray, JL; Hu, QX; DeLeeuw, L; Moore, PS; Chang, Y; Peiper, SC
      Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: Differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II binding

      JOURNAL OF MOLECULAR BIOLOGY
    62. Tkachuk, AN; Moormann, AM; Poore, JA; Rochford, RA; Chensue, SW; Mwapasa, V; Meshnick, SR
      Malaria enhances expression of CC chemokine receptor 5 on placental macrophages

      JOURNAL OF INFECTIOUS DISEASES
    63. Cawthon, AG; Lu, HP; Alexander-Miller, MA
      Peptide requirement for CTL activation reflects the sensitivity to CD3 engagement: Correlation with CD8 alpha beta versus CD8 alpha alpha expression

      JOURNAL OF IMMUNOLOGY
    64. Denkberg, G; Cohen, CJ; Reiter, Y
      Critical role for CD8 in binding of MHC tetramers to TCR: CD8 antibodies block specific binding of human tumor-specific MHC-Peptide tetramers to TCR

      JOURNAL OF IMMUNOLOGY
    65. Ebert, LM; McColl, SR
      Coregulation of CXC chemokine receptor and CD4 expression on T lymphocytesduring allogeneic activation

      JOURNAL OF IMMUNOLOGY
    66. Lehner, T; Doyle, C; Wang, YF; Babaahmady, K; Whittall, T; Tao, L; Bergmeier, L; Kelly, C
      Immunogenicity of the extracellular domains of C-C chemokine receptor 5 and the in vitro effects on simian immunodeficiency virus or HIV infectivity

      JOURNAL OF IMMUNOLOGY
    67. Dragic, T
      An overview of the determinants of CCR5 and CXCR4 co-receptor function

      JOURNAL OF GENERAL VIROLOGY
    68. Hamad, ARA; Srikrishnan, A; Mirmonsef, P; Broeren, CPM; June, CH; Pardoll, D; Schneck, JP
      Lack of coreceptor allows survival of chronically stimulated double-negative alpha/beta T cells: Implications for autoimmunity

      JOURNAL OF EXPERIMENTAL MEDICINE
    69. de la Calle-Martin, O; Hernandez, M; Ordi, J; Casamitjana, N; Arostegui, JI; Caragol, I; Ferrando, M; Labrador, M; Rodriguez-Sanchez, JL; Espanol, T
      Familial CDS deficiency due to a mutation in the CD8 alpha gene

      JOURNAL OF CLINICAL INVESTIGATION
    70. Philpott, S; Weiser, B; Anastos, K; Kitchen, CMR; Robison, E; Meyer, WA; Sacks, HS; Mathur-Wagh, U; Brunner, C; Burger, H
      Preferential suppression of CXCR4-specific strains of HIV-1 by antiviral therapy

      JOURNAL OF CLINICAL INVESTIGATION
    71. Loetscher, P; Pellegrino, A; Gong, JH; Mattioli, I; Loetscher, M; Bardi, G; Baggiolini, M; Clark-Lewis, I
      The ligands of CXC chemokine receptor 3, I-TAC, Mig, and IP10, are naturalantagonists for CCR3

      JOURNAL OF BIOLOGICAL CHEMISTRY
    72. Zhou, NM; Luo, ZW; Luo, JS; Liut, DX; Hall, JW; Pomerantz, RJ; Huang, ZW
      Structural and functional characterization of human CXCR4 as a chemokine receptor and HIV-1 co-receptor by mutagenesis and molecular modeling studies

      JOURNAL OF BIOLOGICAL CHEMISTRY
    73. Venkatesan, S; Petrovic, A; Locati, M; Kim, YO; Weissman, D; Murphy, PM
      A membrane-proximal basic domain and cysteine cluster in the C-terminal tail of CCR5 constitute a bipartite motif critical for cell surface expression

      JOURNAL OF BIOLOGICAL CHEMISTRY
    74. Kraft, K; Olbrich, H; Majoul, I; Mack, M; Proudfoot, A; Oppermann, M
      Characterization of sequence determinants within the carboxyl-terminal domain of chemokine receptor CCR5 that regulate signaling and receptor internalization

      JOURNAL OF BIOLOGICAL CHEMISTRY
    75. Maeda, K; Yoshimura, K; Shibayama, S; Habashita, H; Tada, H; Sagawa, K; Miyakawa, T; Aoki, M; Fukushima, D; Mitsuya, H
      Novel low molecular weight spirodiketopiperazine derivatives potently inhibit R5 HIV-1 infection through their antagonistic effects on CCR5

      JOURNAL OF BIOLOGICAL CHEMISTRY
    76. Percherancier, Y; Planchenault, T; Valenzuela-Fernandez, A; Virelizier, JL; Arenzana-Seisdedos, F; Bachelerie, F
      Palmitoylation-dependent control of degradation, life span, and membrane expression of the CCR5 receptor

      JOURNAL OF BIOLOGICAL CHEMISTRY
    77. Blanpain, C; Wittamer, V; Vanderwinden, JM; Boom, A; Renneboog, B; Lee, B; Le Poul, E; El Asmar, L; Govaerts, C; Vassart, G; Doms, RW; Parmentier, M
      Palmitoylation of CCR5 is critical for receptor trafficking and efficient activation of intracellular signaling pathways

      JOURNAL OF BIOLOGICAL CHEMISTRY
    78. Gerlach, LO; Skerlj, RT; Bridger, GJ; Schwartz, TW
      Molecular interactions of cyclam and bicyclam non-peptide antagonists withthe CXCR4 chemokine receptor

      JOURNAL OF BIOLOGICAL CHEMISTRY
    79. Straube, F; Herrmann, T
      Differential modulation of CD8 beta by rat gamma delta and alpha beta T cells after activation

      IMMUNOLOGY
    80. Moody, AM; Xiong, Y; Chang, HC; Reinherz, EL
      The CD8 alpha beta co-receptor on double-positive thymocytes binds with differing affinities to the products of distinct class I MHC loci

      EUROPEAN JOURNAL OF IMMUNOLOGY
    81. Doucey, MA; Legler, DF; Boucheron, N; Cerottini, JC; Bron, C; Luescher, IF
      CTL activation is induced by cross-linking of TCR/MHC-peptide-CD8/p56(lck)adducts in rafts

      EUROPEAN JOURNAL OF IMMUNOLOGY
    82. Kawamura, T; Qualbani, M; Thomas, EK; Orenstein, JM; Blauvelt, A
      Low levels of productive HIV infection in Langerhans cell-like dendritic cells differentiated in the presence of TGF-beta 1 and increased viral replication with CD40 ligand-induced maturation

      EUROPEAN JOURNAL OF IMMUNOLOGY
    83. Guimezanes, A; Barrett-Wilt, GA; Gulden-Thompson, P; Shabanowitz, J; Engelhardt, VH; Hunt, DF; Schmitt-Verhulst, AM
      Identification of endogenous peptides recognized by in vivo or in vitro generated alloreactive cytotoxic T lymphocytes: distinct characteristics correlated with CD8 dependence

      EUROPEAN JOURNAL OF IMMUNOLOGY
    84. Bardi, G; Lipp, M; Baggiolini, M; Loetscher, P
      The T cell chemokine receptor CCR7 is internalized on stimulation with ELC, but not with SLC

      EUROPEAN JOURNAL OF IMMUNOLOGY
    85. Burger, H; Weiser, B
      Biology of HIV-1 in women and men

      CLINICAL OBSTETRICS AND GYNECOLOGY
    86. Hanna, Z; Rebai, N; Poudrier, J; Jolicoeur, P
      Distinct regulatory elements are required for faithful expression of humanCD4 in T cells, macrophages, and dendritic cells of transgenic mice

      BLOOD
    87. Del Corno, M; Liu, QH; Schols, D; Clercq, EC; Gessani, S; Freedman, BD; Collman, RG
      HIV-1 gp120 and chemokine activation of Pyk2 and mitogen-activated proteinkinases in primary macrophages mediated by calcium-dependent, pertussis toxin-insensitive chemokine receptor signaling

      BLOOD
    88. Guerriero, R; Mattia, G; Testa, U; Chelucci, C; Macioce, G; Casella, I; Samoggia, P; Peschle, C; Hassan, HJ
      Stromal cell-derived factor 1 alpha increases polyploidization of megakaryocytes generated by human hematopoietic progenitor cells

      BLOOD
    89. Gear, ARL; Suttitanamongkol, S; Viisoreanu, D; Polanowska-Grabowska, RK; Raha, S; Camerini, D
      Adenosine diphosphate strongly potentiates the ability of the chemokines MDC, TARC, and SDF-1 to stimulate platelet function

      BLOOD
    90. Tamasauskas, D; Powell, V; Saksela, K; Yazdanbakhsh, K
      A homologous naturally occurring mutation in Duffy and CCR5 leading to reduced receptor expression

      BLOOD
    91. Gallo, SA; Puri, A; Blumenthal, R
      HIV-1 gp41 six-helix bundle formation occurs rapidly after the engagement of gp120 by CXCR4 in the HIV-1 Env-mediated fusion process

      BIOCHEMISTRY
    92. Staudinger, R; Wang, XH; Bandres, JC
      Allosteric regulation of CCR5 by guanine nucleotides and HIV-1 envelope

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    93. Misumi, S; Takamune, N; Ido, Y; Hayashi, S; Endo, M; Mukai, R; Tachibana, K; Umeda, M; Shoji, S
      Evidence as a HIV-1 self-defense vaccine of cyclic chimeric dodecapeptide warped from undecapeptidyl arch of extracellular loop 2 in both CCR5 and CXCR4

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    94. Song, W; Yahara, S; Maeda, Y; Yusa, K; Tanaka, Y; Harada, S
      Enhanced infection of an X4 strain of HIV-1 due to capping and colocalization of CD4 and CXCR4 induced by capsianoside G, a diterpene glycoside

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    95. Youn, BS; Yu, KY; Alkhatib, G; Kwon, BS
      The seventh transmembrane domain of CC chemokine receptor 5 is critical for MIP-1 beta binding and receptor activation: Role of Met 287

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    96. Clayton, F; Kotler, DP; Kuwada, SK; Morgan, T; Stepan, C; Kuang, JQ; Le, J; Fantini, J
      Gp120-induced Bob/GPR15 activation - A possible cause of human immunodeficiency virus enteropathy

      AMERICAN JOURNAL OF PATHOLOGY
    97. Tremblay, CL; Kollmann, C; Giguel, F; Chou, TC; Hirsch, MS
      Strong in vitro synergy between the fusion inhibitor T-20 and the CXCR4 blocker AMD-3100

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    98. Castillo, RC; Arango-Jaramillo, S; John, R; Tuner, BC; Zimmerman, E; Schwartz, DH
      Development of in vitro resistance to macrophage-tropic- and T-cell-line-adapted HIV-1 strains among HIV-positive volunteers treated with highly active antiretroviral therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    99. Tscherning-Casper, C; Vodros, D; Menu, E; Aperia, K; Fredriksson, R; Dolcini, G; Chaouat, G; Barre-Sinoussi, F; Albert, J; Fenyo, EM
      Coreceptor usage of HIV-1 isolates representing different genetic subtypesobtained from pregnant Cameroonian women

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    100. Brice, GT; Mayne, AE; Villinger, F; Ansari, AA
      A novel role for tumor necrosis factor-alpha in regulating susceptibility of activated CD4(+) T cells from human and nonhuman primates for distinct coreceptor using lentiviruses

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 31/03/20 alle ore 23:33:11